Wisconsin Sees First Allocation of Oral Antiviral COVID Treatments

Thursday, January 6th, 2022 -- 2:01 PM

(Bob Hague, WRN) Wisconsin receives its first allocation of oral antiviral COVID-19 treatments.

The Department of Health Services has received the first, extremely limited supply (of molnupiravir and Paxlovid) to treat patients diagnosed with mild to moderate COVID-19.

Health care providers are encouraged to prioritize prescribing the new therapeutics to patients at greatest risk of serious illness or hospitalization from COVID-19. People who may be eligible should talk with their health care provider.

Feel free to contact us with questions and/or comments.